date,title,content,company
"  January 27, 2023 / 09:38 AM IST  ","Hindenburg says holds short positions in India's Adani, flags risks","Short-seller Hindenburg Research said on Wednesday it holds short positions in India's Adani Group companies through U.S.-traded bonds and non-Indian-traded derivative instruments.The seven listed companies of the Adani group, which is controlled by world's third richest man Gautam Adani, have an 85% downside on a fundamental basis due to sky-high valuations, Hindenburg said in the report.To catch all the latest updates from around the world, follow moneycontrol's LIVE blog here""Key listed Adani companies have also taken on substantial debt, including pledging shares of their inflated stock for loans, putting the entire group on precarious financial footing,"" Hindenburg said.An Adani spokesperson did not immediately respond to Reuters request for comment on the report. The company has repeatedly dismissed debt concerns.Adani Chief Financial Officer Jugeshinder Singh said on Jan. 21 ""Nobody has raised debt concerns to us. No single investor has."" Adani Enterprises, the flagship company of ports-to-energy conglomerate Adani Group, has said it will raise $2.5 billion in India's largest follow-on public offering due this Friday.Also read: Truck operators say Adani Cement’s ask is unviable; ACC dealers hurt by supply disruptions Shares of Adani Enterprises surged 125% in 2022, while other group companies, including power and gas units, rose over 100%.Adani Group's total gross debt in the financial year ending March 31, 2022, rose 40% to 2.2 trillion rupees. CreditSights, part of the Fitch Group, described the group last September as ""overleveraged"" and said it had ""concerns"" over its debt.While the report later corrected some calculation errors, CreditSights said it maintained concerns over leverage.",Adani Enterprises Ltd.
"  January 27, 2023 / 09:39 AM IST  ","Adani Group responds to Hindenburg report, calls it 'malicious'","Adani Group's Chief Financial Officer, Jugeshinder Singh, said in a statement that the company was shocked by the report, calling it a ""malicious combination of selective misinformation and stale, baseless and discredited allegations.""""The timing of the report’s publication clearly betrays a brazen, mala fide intention to undermine the Adani Group’s reputation with the principal objective of damaging the upcoming follow-on Public Offering from Adani Enterprises,"" it added.Also read: Hindenburg says holds short positions in India's Adani, flags risks""The Group has always been in compliance with all laws.""Hindenburg said its report was based on an investigation over two years that involved speaking with dozens of individuals, including former Adani Group executives as well as a review of documents.India's capital markets regulator, the Securities and Exchange Board of India, did not immediately respond to a request for comment.Adani has repeatedly dismissed debt concerns. Singh told media on Jan. 21 ""Nobody has raised debt concerns to us. No single investor has.""In the wake of the Hindenburg report, shares in Adani Ports And Special Economic Zone fell 7.3% to their lowest level since early July. Adani Enterprises dropped 3.7% to a near three-month low.Adani-owned cement firms ACC and Ambuja Cements, which it acquired from Switzerland's Holcim last year in a $10.5 billion deal, fell 7.2% and 9.7% respectively on Wednesday.Hindenburg's report said that five of seven key listed Adani companies have reported current ratios - a measure of liquid assets minus near-term liabilities - below 1. This, the short-seller said, suggested ""a heightened short-term liquidity risk"".Adani Group's total gross debt in the financial year ending March 31, 2022, rose 40% to 2.2 trillion rupees.Refinitiv data shows that debt at Adani Group's seven key listed Adani companies exceeds equity, with debt at Adani Green Energy Ltd (ADNA.NS) exceeding equity by more than 2,000%.CreditSights, part of the Fitch Group, described the group last September as ""overleveraged"" and said it had concerns about its debt. While the report later corrected some calculation errors, CreditSights said it maintained its concerns about Adani's leverage.Hindenburg is known for shorting electric truck maker Nikola Corp (NKLA.O) and Twitter though it later reversed its position in Twitter.Shares in Adani Enterprises surged 125% in 2022, while other group companies, including power and gas units, rose more than 100%.",Ambuja Cements Ltd.
"  January 27, 2023 / 11:04 AM IST  ",Bajaj Auto Q3 FY23: Valuation a draw for long-term investors,"                        Highlights:

	Export markets got marred by macroeconomic challenges
	Rich product mix and raw material prices helped operating margins
	Business outlook positive for medium to long term
	Export markets are expected to revive from Q1 FY24
	Stock trading at reasonable valuation; buy with long-term perspective

Significant softening of commodity-linked raw material cost coupled with rich product mix helped Bajaj Auto (CMP: Rs 3,717; M Cap: Rs 1,07,600 crore) to arrest the impact of decline in volumes. In fact, the company registered significant expansion in the operating...
                    ",Bajaj Auto Ltd.
"  January 27, 2023 / 09:43 AM IST  ",Bajaj Auto vrooms as Q3 profit rises 23%; brokerages raise target price,"Bajaj Auto shares rallied over 6 percent on January 27 after the company reported better-than-expected numbers in the quarter ended December 2022. The two-wheeler major reported a standalone net profit of Rs 1,491 crore for the quarter ended December 2022, clocking a 23 percent rise over Rs 1,214 crore a year ago.At 9:30 am, the stock was quoting at Rs 3,944 per share on the National Stock Exchange, higher by 6.10 percent. Trading volumes at 7,02,660 shares were almost three times the 20-day average volumes of 2,69,188 shares.Revenue from operations came in at Rs 9,315 crore, increasing 3 percent from Rs 9,022 crore in the corresponding quarter last year, the company said in an exchange filing on January 25.Catch all the market action on our live blogHere is what brokerages have to say about stock and the company post December quarter earnings:Prabhudas LilladherMaintain ‘Hold' with target price increased to Rs 4,040 from Rs 3,820 earlier. Increase FY24/25 EPS estimates by 4% each to factor in higher ASPs and better mixRemain concerned on the export side (~50% of sales) of the business given currency devaluation and unavailability of dollar, lower affordability due to price hikes and higher interest rates.Expect company's domestic premium segment volumes to grow (similar to the industry), given stabilization in semiconductor supply.SharekhanMaintain 'Buy' with an unchanged Price Target of Rs 4,151Though company has been facing challenges in the export market but maintaining a leadership position in its key markets. This would accelerate its volume growth when business cycle returns to normal levelsExpect company to continue to increase its market share in domestic and export markets, given its strong portfolio of premium brands and cost-effective entry-level productsBelieve that company's diversified geography mix and strong presence in the domestic premium motorcycle segment allows it to support its operating performance even in weak business scenario.JPMorganBroking house has upgraded the stock to overweight due to strong earnings beat in Q3 despite weak volumes, increasing aggression on EVs and likely bottoming of exports & potential recovery in H1FY24.The broking house also raised the target price to Rs 4,400 per share.Rising focus on EVs & core business are likely to bottom and current valuations reflect favourable risk reward. JPMorgan raises FY23-25 EPS estimates by 8-13%, reported CNBC-TV18.Morgan StanleyResearch firm has kept ‘Overweight’ rating on the stock with a target at Rs 4,449 per share. The research firm having a ‘contrarian overweight’ on Bajaj Auto.EV launches & successful premium cruiser launch with triumph could drive re-rating, reported CNBC-TV18CLSABroking firm has maintained ‘Buy’ rating and raised the target price to Rs 4,619 per share.Lower raw material costs, better FX realisation & richer product mix led to expansion in margin.Increase earnings estimates to 14%/15% for FY24/25 on higher revenue & margin assumptions, reported CNBC-TV18JefferiesBroking house has kept ‘Buy’ rating on the stock with a target at Rs 4,300 per share.The Q3 volumes were down but EBITDA & PAT grew with both were 12-18% above estimates led by better-than-expected ASP & margin. Also, EBITDA/vehicle rose to an all-time high.Jefferies believes that domestic 2-wheelers are ripe for recovery from an abnormal cyclical trough. The exports are also facing macro pressures, but company expects improvement by mid-2023, reported CNBC-TV18Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Bajaj Auto Ltd.
"  January 27, 2023 / 12:49 PM IST  ",Cipla: Sharp improvement in margins not likely to sustain,"                        Highlights

	Top-line growth lacks shine; however, US stands out
	Chronic therapies help underlying domestic sales 
	Elevated competition in South Africa business
	Product launches in US aid margin expansion
	Key near-term watch is traction in peptide assets
	Valuation ahead of peers

While the Q3FY23 top-line numbers were uninspiring for Cipla (CMP: Rs 1,035; Market Cap: Rs 83,560 crore), the US business stood out due to product launches. Product mix also contributed to better gross margins though its sustenance is questionable.

In the coming days, traction for peptide...
                    ",Cipla Ltd.
"  January 27, 2023 / 08:37 AM IST  ","Cipla Q3 profit up 10%, brokerages remain positive","Shares of Cipla Limited will be in focus on January 27 after the Indian pharmaceutical major posted a consolidated profit after tax (PAT) of Rs 801 crore for Oct-Dec quarter, rising by 10 percent. It had reported a profit of Rs 789 crore in the September'22 quarter.Consolidated revenue came in higher year on year by 6 percent at Rs 5,801 crore, compared to Rs 5,479 crore logged during the same period in 2021. Revenue in Q2FY23 stood at Rs 5,829 crore.Catch all the market action on our live blogHere is what brokerages have to say about stock and the company post December quarter earnings:Nirmal BangBroking house remains positive on Cipla mainly due to its strong India franchise, robust US pipeline, healthy margins and improving return ratios.The firm cut its estimates to factor in 3QFY23 performance and lower-than-expected Revlimid sales.Maintain 'Buy' on Cipla with a revised target price of Rs 1,263Prabhudas LilladherMaintain ‘Buy’ rating with revised Target Price of Rs 1,280 from Rs 1,300 earlierBroking house reduce its FY24/FY25 earnings by ~4 percent factoring in delay in key US launches and lower marginsContinue to remain positive on company’s growth across key segments including India and US given strong traction in respiratory and other portfolio, domestic formulation to potentially grow 10 percent going forward and sustainability of current US revs, backed by potential key launches.MacquarieBrokerage house has kept ‘Outperform’ rating on the stock with a target at Rs 1,235 per share as Q3 revenue/EBITDA/PAT missed estimates by 7 percent, 6 percent, 14 percent.As FY23 EBITDA margin guidance of 21 to 22 percent has been maintained, lowered the FY23/FY24/FY25 EPS estimates to 8 percent, 5 percent, 3 percent to reflect Q3 miss & delay for Advair.Current stock price is factoring in Q3 miss & Advair delay, reported CNBC-TV18.Kotak Institutional EquitiesResearch firm has kept ‘Buy’ rating on the stock with a target at Rs 1,255 per share.The steady Q3 with softness in SAGA being partially offset by strength in US & higher gross margin.Expect company’s US sales to deliver healthy 18% CAGR over FY22-25. With domestic performance stays on track, SAGA is expected to pick up Q1FY24 onwards.Kotak Institutional Equities expect Cipla to deliver robust 24% EPS CAGR over FY22-25, reported CNBC-TV18.Morgan StanleyBrokerage house has kept ‘Overweight’ rating on the stock with a target at Rs 1,336 per share.Cipla continues to enrich its US pipeline with inhalers and peptides with good visibility of 3-4 complex launches every year for next 3 years, reported CNBC-TV18.Jefferies Broking house has maintained ‘Hold’ rating on the stock with a target at Rs 1,100 per share.The Q3 numbers missed revenue/EBITDA estimates by 6 percent on revenue decline in SAGA & muted growth in India.US was strong on back of seasonality & market share gains in key products, while India & SAGA growth should recover.The high impact US launches for FY24 have been delayed, poses downside risk to consensus estimates, reported CNBC-TV18.Expect 18 percent EPS CAGR over FY23-25E given resilient earnings, improving US visibility and strong free cash flow generation.Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Cipla Ltd.
"  January 27, 2023 / 05:30 PM IST  ","MC BudEx falls 3% dragged down by Dixon Technologies, Adani Ports","As bears gripped Dalal Street, Moneycontrol's Budget Sensitivity Index (MC BudEx) fell 3.04 percent on January 27 dragged down by infrastructure, manufacturing, and banking names. In comparison, Nifty and Sensex fell about 1.5 percent each.Top losers on the MC BudEx were Dixon Technologies, Adani Ports, IRB Infra, and Bank of Baroda. Of the total 30 stocks, Dabur India, ITC, Tata Power, and Mahindra & Mahindra were the only stocks that ended in the green.Electronics manufacturing services firm Dixon Technologies was the biggest loser, falling over 18 percent after the company cut its FY23 revenue guidance to Rs 12,200 crore ‐Rs 12,700 crore from Rs 15,000 crore.The company's revenue from operations fell 22 percent year-on-year to Rs 2,405 crore. ""We have lowered our guidance primarily due to a slowdown in the mobile business. There is a likelihood of FY24 revenue guidance to be lowered from Rs 19,000 crore,"" group CFO Saurabh Gupta told CNBC-TV18.Weak consumer demand and lower prices of pass-through inputs also led to revenue miss, said analysts. With Budget 2023 right around the corner, all eyes will be on how the Government plans to boost consumption in India.Several consumer companies part of the MC BudEx have highlighted weak demand trends in rural and semi-urban areas amid high retail inflation.Also Read Budget 2023: As discretionary demand dwindles, industry wish list runs longAdani Ports was the other big loser on the MC BudEx, declining over 15 percent. The stock has shed over 25 percent year-to-date. Adani Ports was followed by Bank of Baroda which closed 7.4 percent lower. Bank of Baroda was also the biggest loser on Nifty Bank, which ended down by 3.13 percent.""Participants were already facing challenges due to mixed global cues and caution ahead of the Union Budget and today's breakdown in markets has further added to worries,"" Ajit Mishra, VP - of Technical Research, Religare Broking said.Some part of India’s underperformance vis-à-vis global markets off late can be explained by the huge outperformance by India last year, believes Nishit Master, Portfolio Manager, Axis Securities. ""Markets are attempting to revert back to the mean,"" he said.Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.",Dixon Technologies (India) Ltd.
"  January 27, 2023 / 10:51 AM IST  ","Dixon Technologies tanks 18% in worst-ever fall on weak Q3, FY23 guidance cut","Electronics manufacturing services firm Dixon Technologies fell over 18 percent on January 27 morning after the company cut its FY23 revenue guidance to Rs 12,200 crore ‐Rs 12,700 crore from Rs 15,000 crore following a weak October-December quarter.At 10 am, the stock was quoting at Rs 2,740 a share on the National Stock Exchange, down 18.32 percent, its worst fall since September 18, 2017 when it made its market debut. Trading volumes at 1.9 million shares were about ten times the 20-day average volume of 1.4 lakh shares.Follow our live blog for all the market actionThe company's revenue from operations fell 22 percent year-on-year to Rs 2,405 crore while its net profit grew 13 percent to Rs 52 crore. Operating margins improved from 3.4 percent to 4.7 percent.Mobile business in the slow laneSpeaking to CNBC-TV18, group CFO Saurabh Gupta said, ""We have lowered our guidance primarily due to a slowdown in the mobile business. Export market has slowed. There is a likelihood of FY24 revenue guidance to be lowered from Rs 19,000 crore.""The company's consumer electronics segment revenue fell 39 percent YoY to Rs 864 crore. Lighting products' revenue also fell 39 percent YoY to Rs 263 crore. Mobile & EMS Division revenue fell 3 percent YoY and 43 percent sequentially to Rs 915 crore.Foreign brokerage firm Credit Suisse has downgraded the stock to ""neutral"" with the target cut to Rs 3,300 from Rs 4,500 a share. ""Results were disappointing, valuations leave limited upside. Mobile revenue to contract sequentially with stall in Motorola business,"" the firm said.Weak consumer demand and lower prices of pass-through inputs led to revenue miss, it added.Nuvama Institutional Equities has cut FY23-24 estimates by 35-20 percent after weak results. ""But. growth seems healthy despite these cuts (with 30 percent return on equity). Hence, we retain Buy with a target price of Rs 3,865,"" it said.Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.​​​​​​​​​​​​​",Dixon Technologies (India) Ltd.
"  January 27, 2023 / 10:02 AM IST  ","Another great quarter for Dr Reddy’s, but is it sustainable?","                        Highlights

	Q3 benefits from g-Revlimid sales in the US & biosimilar sales in Russia
	India business lags industry but work-in-progress for increase in chronic portfolio
	Key risk is intensification of competition in the US and Indian markets
	Key watch is filing of Rituximab in US and Europe markets

Dr Reddy’s (CMP: Rs 4,201; Market cap: Rs 69,956 crore) posted strong results for Q3FY23, backed by the traction in generic version of Revlimid (g-Revlimid) and an institutional tender win in the Russian market.

While some of...
                    ",Dr. Reddy's Laboratories Ltd.
"  January 27, 2023 / 09:51 AM IST  ",Dr Reddy’s Q3 consolidated profit jumps 77%; what should investors do with the stock?,"Dr Reddy's Laboratories share price will remain in focus on January 27 after company announced its December quarter results on Wednesday.Pharma major Dr Reddy's Laboratories on January 25 reported a 77 percent growth in consolidated net profit at Rs 1,247 crore for the quarter ended December 31, 2022 as against Rs 707 crore a year ago. On a sequential basis, the profit grew 12 percent.The Hyderabad-based drug maker also reported a 27 percent increase in consolidated revenue at Rs 6,770 crore as against Rs 5,320 crore in the year-ago period, while it was up 7 percent sequentially.Catch all the market action on our live blogHere is what brokerages have to say about stock and the company post December quarter earnings:MacquarieResearch house has kept ‘Outperform’ rating on the stock with a target at Rs 4,915 per share as Q3 revenue/EBITDA/PAT beat estimates by 9 percent/37 percent/35 percent, respectively.Macquarie raises FY23 earnings estimates by 8 percent, while largely maintain FY24E/25 earnings estimates.Capital deployment priorities are clear, but have yet to see any firm action, reported CNBC-TV18.Morgan StanleyBroking house has kept ‘Overweight’ rating with target at Rs 5,099 per share.The strong Q3 driven largely by Revlimid and should continue for next several quarters.The core business is stable, while M&A is a focus area given strong balancesheet, reported CNBC-TV18.Nirmal BangMaintain 'Accumulate' rating on the stock with a revised target price of Rs 4,745Believe that the company has reported USD 120-130mn Revlimid revenue (with ~75% margin), almost double than the estimateExcluding Revlimid, do not expect the company to achieve 25% guided EBITDA margin on an annualized basis, at least in the near to medium termDisclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Dr. Reddy's Laboratories Ltd.
"  January 27, 2023 / 09:58 AM IST  ",Pidilite: Why we stay neutral despite raw material tailwinds,"                        Highlights:

	Pricing-led growth, volume remains elusive
	Margins likely to recover with correction in raw material prices
	Competitive intensity likely to increase
	Remain neutral, given the valuation captures most of the positives

The Q3FY2023 performance of Pidilite Industries (CMP: Rs2316) was below market expectations. The demand remained resilient in the Tier 1, 2 & 3 markets, while rural markets were impacted by higher inflation. VAM (vinyl acetate monomer) prices have corrected significantly from their highs and we expect margins to recover in the March23 quarter.

Key...
                    ",Pidilite Industries Ltd.
"  January 27, 2023 / 10:22 AM IST  ",Tata Elxsi rises after Q3 profit grows 29%; Morgan Stanley still sees 14% downside,"Tata Elxsi share price edged higher during early trade on January 27 despite weak market conditions. At 09:53 am, the stock quoted Rs 6,657.50, up Rs 60.70, or 0.92 percent.The company reported its earnings for Oct-Dec wherein net profit came in at Rs 194.68 crore, up 28.97 percent from Rs. 150.95 crore in December 2021. EBITDA came in at Rs. 265.99 crore in the given quarter, up 22.38 percent from Rs 217.35 crore in a year ago.The company has reported EPS of Rs. 31.26 for the period ended December 31, 2022 as compared to Rs. 27.98 for the period ended September 30, 2022.It also reported total income of Rs 836.87 crore during the period ended December 31, 2022 as compared to Rs 641.9244 crore during the period ended December 31, 2021.Catch all the market action on our live blogHowever, global research and broking firm Morgan Stanley has an underweight rating on the stock with target at Rs 5,800 per share, a down side of 14 percent from current market price.""Embedded Product Design (EPD) business slowed for fifth straight quarter affected by furloughs and project deferments while commentary on outlook is balanced. Cost normalisation and ESOP costs should keep margin expectations in check,"" it said.Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.​",Tata Elxsi Ltd.
"  January 27, 2023 / 09:23 AM IST  ","Tata Elxsi Standalone December 2022 Net Sales at Rs 817.74 crore, up 28.69% Y-o-Y","Net Sales at Rs 817.74 crore in December 2022 up 28.69% from Rs. 635.41 crore in December 2021.Quarterly Net Profit at Rs. 194.68 crore in December 2022 up 28.97% from Rs. 150.95 crore in December 2021.EBITDA stands at Rs. 265.99 crore in December 2022 up 22.38% from Rs. 217.35 crore in December 2021.Tata Elxsi EPS has increased to Rs. 31.26 in December 2022 from Rs. 24.24 in December 2021.Tata Elxsi shares closed at 6,597.20 on January 25, 2023 (NSE) and has given -22.65% returns over the last 6 months and -6.30% over the last 12 months.",Tata Elxsi Ltd.
"  January 27, 2023 / 11:05 AM IST  ","Tata Motors Q3 FY23: A strong quarter for both India, international businesses","                        Highlights

	New products and the easing of chip supply helped JLR’s operating margin
	Softening of raw material prices and higher realisation helped domestic business margins
	Aggressive focus on EVs a key trigger for re-rating
	Both JLR and domestic business expected to perform well on the back of strong demand
	SOTP valuation suggests stock has upside potential
With the waning impact of semiconductor chip shortage and the softening of raw material prices, Tata Motors (TML; CMP: Rs 419; Market cap: Rs 1,50,100 crore) posted a strong...
                    ",Tata Motors Ltd.
"  January 27, 2023 / 09:30 AM IST  ","Tata Motors races on profit after 7 quarters, what should you do with the stock?","Tata Motors raced over 7 percent on January 27 after December quarter earnings beat estimates.On January 25, the company reported a consolidated net profit of Rs 2,957.71 crore for the quarter ended December 2022, against a loss of Rs 1,516.14 crore in the same quarter last year.The company posted profit after recording losses for seven consecutive quarters.At 9:30 am, the stock was quoting at Rs 448.20 apiece on the National Stock Exchange, up by 7 percent. Trading volumes were 15.2 million shares.Revenue from operations came in at Rs 88,488.59 crore, up 22.51 percent from Rs 72,229.29 crore in the same quarter last year, Tata Motors said in an exchange filing.Catch all the market action on our live blogHere is what brokerages have to say about stock and the company post December quarter earnings:SharekhanMaintain 'Buy' with an unchanged Price Target of Rs 516.Company is witnessing robust demand and is expected to deliver better operational efficiencies, aided by aggressive launches, market positioning, product differentiation, cost savings, and investments in research and development (R&D).Expect operational performance to improve strongly in Q4FY23E and FY24E, as supply constraints are expected to ease gradually, while demand remains strong for both JLR and domestic operations.Domestic CV and PV segments are expected to remain healthy because of new launches and operating leverage benefits.NomuraResearch firm has kept ‘Buy’ rating on the stock with a target at Rs 508 per share.The Q3 margin improves across segments. JLR to benefit from rising chip supply and India CV strategy to reduce disc working well.Company management says JLR Q4 volumes may be 85,000 & improve further in FY24.Nomura maintains volume estimates for JLR for FY23-25 at 3.67 lakh/4.70 lakh/4.78 lakh and maintain EBITDA margin estimates for JLR for FY23-25 at 10.3 percent/14.1 percent/14 percent, reported CNBC-TV18.JefferiesBrokerage house has maintained ‘Buy’ rating on the stock and raised the target price to RS 565 per share.The Q3 EBITDA grew to a 7-quarter high and was 25 percent above the estimates, while EBITDA/vehicle rose at JLR & India CVs led by better mix and pricing.JLR maintained its Q4 guidance & expects chip constraints to ease gradually.The company has strong order book with 74 percent of orders for new RR, RR-sport & defender.Jefferies expect lower net loss in FY23 & raise FY24-25 EPS by 3-5 percent, reported CNBC-TV18.Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.",Tata Motors Ltd.
"  January 27, 2023 / 07:22 AM IST  ",Stock Market Today: Top 10 things to know before the market opens,"The market is expected to open in the green on January 27 as trends in the SGX Nifty indicate a positive opening for the broader index in India with a gain of 74 points.In the previous session on Wednesday, the BSE Sensex tanked 774 points to 60,205, while the Nifty50 plunged 226 points - the biggest loss in a day since December 23 (2022) - to 17,892 and formed long bearish candle on the daily charts with lower high lower low formation, indicating negative mood among market participants. The market was closed on January 26 on account of Republic Day.As per the pivot charts, we have the key support level for the Nifty at 17,849, followed by 17,789, and 17,789. If the index moves up, the key resistance levels to watch out for are 18,043, followed by 18,103 and 18,201.Stay tuned to Moneycontrol to find out what happens in the currency and equity markets today. We have collated a list of important headlines across news platforms which could impact Indian as well as international markets:US MarketsWall Street ended a choppy session higher on Thursday as investors grappled with an onslaught of economic data and a string of mixed corporate earnings, all while eyeing the clock as it ticks down toward next week's Federal Reserve monetary policy meeting.The Dow Jones Industrial Average rose 205.57 points, or 0.61%, to 33,949.41, the S&P 500 gained 44.21 points, or 1.10%, to 4,060.43 and the Nasdaq Composite added 199.06 points, or 1.76%, to 11,512.41.Asian MarketsStocks in the Asia-Pacific traded higher on Friday as Wall Street’s major indexes gained after the US economy grew more than expected. Government data showed the economy expanded at an annualized rate of 2.9% during the fourth quarter, higher than expectations.Nikkei 225 rose 0.11% in its first hour of trade and the Topix gained 0.18%. In Australia, the S&P/ASX 200 traded 0.23% higher. In South Korea, the Kospi was flat.SGX NiftyTrends in the SGX Nifty indicate a positive opening for the broader index in India with a gain of 74 points. The Nifty futures were trading around 18,028 levels on the Singaporean exchange.US economy posts strong growth in Q4, but with underlying weaknessThe US economy grew faster than expected in the fourth quarter, but that likely exaggerates the nation's health as a measure of domestic demand rose at its slowest pace in 2-1/2 years, reflecting the impact of higher borrowing costs.The Commerce Department's advance fourth-quarter gross domestic product report on Thursday showed half of the boost to growth came from a sharp rise in inventory held by businesses, some of which is likely unwanted.Gross domestic product increased at a 2.9% annualized rate last quarter. The economy grew at a 3.2% pace in the third quarter. Economists polled by Reuters had forecast GDP would rise at a 2.6% rate.Oil up 1% as positive US data, China reopening boosts demand optimismOil prices rose more than 1% on Thursday on expectations that global demand will strengthen as top oil importer China reopens its economy and on positive US economic data.Brent futures rose $1.18, or 1.4%, to $87.30 a barrel by 11:42 a.m. EST (1642 GMT), while US West Texas Intermediate (WTI) crude rose $1.12, or 1.4%, to $81.27.UN cuts India's 2023 growth forecast by 20 bps to 5.8% on rate hike, global slowdown fearsThe United Nations (UN) has cut its GDP growth forecast for India for calendar year 2023 to 5.8 percent, citing the effect of tighter monetary policy and weak global demand.""Growth in India is expected to remain strong at 5.8 percent, albeit slightly lower than the estimated 6.4 percent in 2022, as higher interest rates and a global slowdown weigh on investment and exports,"" the UN's World Economic Situation and Prospects 2023 report, published on January 25, said.FII and DII dataForeign institutional investors (FII) have net sold shares worth Rs 2,393.94 crore, whereas domestic institutional investors (DII) have net bought shares worth Rs 1,378.49 crore on January 25, as per provisional data available on the NSE.Tata Motors back in black with Q3 net profit at Rs 2,958 crore; beats estimatesTata Motors on January 25 reported a consolidated net profit of Rs 2,957.71 crore for the quarter ended December 2022, against a loss of Rs 1,516.14 crore in the same quarter last year.Revenue from operations came in at Rs 88,488.59 crore, up 22.51 percent from Rs 72,229.29 crore in the same quarter last year, Tata Motors said in an exchange filing.The Street was expecting the auto major to swing back to black with net profit estimates anywhere between Rs 300-800 crore. Consolidated sales were expected to rise over 14.5 percent year on year (YoY) and 3.9 percent sequentially to Rs 82,718 crore, estimates of analysts across four brokerages showed.Results on January 27 and January 28Bajaj Finance, Vedanta, Aarti Drugs, Aditya Birla Sun Life AMC, CMS Info Systems, Glenmark Life Sciences, Godfrey Phillips India, Sterlite Technologies, Zenotech Laboratories, and AIA Engineering will be in focus ahead of quarterly earnings on January 27.NTPC, Bharat Electronics, CARE Ratings, DCB Bank, Five-Star Business Finance, Gujarat Ambuja Exports, Heranba Industries, Kajaria Ceramics, Vedant Fashions, Radiant Cash Management Services, and Zen Technologies will be in focus ahead of quarterly earnings on January 28.Dollar higher as strong US data backs a hawkish FedThe dollar edged higher against the euro on Thursday after data showed the US economy maintained a strong pace of growth in the fourth quarter, backing the case for the US Federal Reserve to maintain its hawkish stance for longer.The euro was 0.23% lower at $1.08895, but not far from the nine-month high of $1.09295 touched on Monday. Against the yen, the dollar was up 0.54% at 130.275 yen.With inputs from Reuters and other agencies",Tata Motors Ltd.
"  January 27, 2023 / 11:54 PM IST  ","Vedanta Standalone December 2022 Net Sales at Rs 15,832.00 crore, down 2.19% Y-o-Y","Net Sales at Rs 15,832.00 crore in December 2022 down 2.19% from Rs. 16,187.00 crore in December 2021.Quarterly Net Profit at Rs. 4,684.00 crore in December 2022 down 27.64% from Rs. 6,473.00 crore in December 2021.EBITDA stands at Rs. 6,337.00 crore in December 2022 down 28.17% from Rs. 8,822.00 crore in December 2021.Vedanta EPS has decreased to Rs. 12.59 in December 2022 from Rs. 17.40 in December 2021.Vedanta shares closed at 326.25 on January 25, 2023 (NSE) and has given 34.04% returns over the last 6 months and -0.59% over the last 12 months.",Vedanta Ltd.
"  January 27, 2023 / 04:58 PM IST  ","Vedanta Q3 result: Net profit plunges 41% to Rs 2,464 crore; announces dividend of Rs 12.5","Vedanta Limited on January 27 reported a 40.81 percent drop in consolidated net profit for the quarter ended December 2022 at Rs 2,464 crore against Rs 4,164 crore in the same quarter last year.The revenue from operations came in at Rs 33,691 crore, down 0.01 percent from Rs 33,697 crore in the corresponding quarter a year ago, the company said in an exchange filing.The Board of Directors of the Company also approved the fourth interim dividend of Rs 12.50 per equity share amounting to Rs 4,647 crore. The record date for the payment is February 4, 2023.“We have delivered a strong set of financial results and steady operational performance in a challenging macroeconomic environment,” Chief Executive Officer Sunil Duggal said.“We have approved plans for another 941 MW RE power under group captive RE power development program. I am also happy to share that Vedanta and Hindustan Zinc Limited Boards have taken a strategic initiative to consolidate Zinc International under Hindustan Zinc.”The company said its quarterly alumina production decreased by 2 percent quarter on quarter (QoQ) to 443 kilotonnes (kt) due to maintenance activities in calciners. Karnataka saleable iron ore production increased by 32 percent QoQ to 1.4mn tonnes. Pig iron production was higher by 66 percent QoQ as the second quarter was impacted by the shut down of smaller blast furnace.Saleable production of steel was of 306kt, lower by 6 percent QoQ due to maintenance activities in blast furnace.The company said it continues to maintain healthy cash and cash equivalents of Rs 23,474 crore as on 31st Dec 2022.",Vedanta Ltd.
